keyword
MENU ▼
Read by QxMD icon Read
search

Ovcar4

keyword
https://www.readbyqxmd.com/read/27147568/functional-characterization-of-a-panel-of-high-grade-serous-ovarian-cancer-cell-lines-as-representative-experimental-models-of-the-disease
#1
James Haley, Sunil Tomar, Nicholas Pulliam, Sen Xiong, Susan M Perkins, Adam R Karpf, Sumegha Mitra, Kenneth P Nephew, Anirban K Mitra
Genomic analysis of ovarian cancer cell lines has revealed a panel that best represents the most common ovarian cancer subtype, high-grade serous ovarian cancer (HGSOC). However, these HGSOC-like cell lines have not been extensively applied by ovarian cancer researchers to date, and the most commonly used cell lines in the ovarian cancer field do not genetically resemble the major clinical type of the disease. For the HGSOC-like lines to serve as suitable models, they need to be characterized for common functional assays...
May 31, 2016: Oncotarget
https://www.readbyqxmd.com/read/27036018/mir-509-3p-is-clinically-significant-and-strongly-attenuates-cellular-migration-and-multi-cellular-spheroids-in-ovarian-cancer
#2
Yinghong Pan, Gordon Robertson, Lykke Pedersen, Emilia Lim, Anadulce Hernandez-Herrera, Amy C Rowat, Sagar L Patil, Clara K Chan, Yunfei Wen, Xinna Zhang, Upal Basu-Roy, Alka Mansukhani, Andy Chu, Payal Sipahimalani, Reanne Bowlby, Denise Brooks, Nina Thiessen, Cristian Coarfa, Yussanne Ma, Richard A Moore, Jacquie E Schein, Andrew J Mungall, Jinsong Liu, Chad V Pecot, Anil K Sood, Steven J M Jones, Marco A Marra, Preethi H Gunaratne
Ovarian cancer presents as an aggressive, advanced stage cancer with widespread metastases that depend primarily on multicellular spheroids in the peritoneal fluid. To identify new druggable pathways related to metastatic progression and spheroid formation, we integrated microRNA and mRNA sequencing data from 293 tumors from The Cancer Genome Atlas (TCGA) ovarian cancer cohort. We identified miR-509-3p as a clinically significant microRNA that is more abundant in patients with favorable survival in both the TCGA cohort (P = 2...
May 3, 2016: Oncotarget
https://www.readbyqxmd.com/read/26879975/genome-wide-transcriptional-regulation-of-estrogen-receptor-targets-in-fallopian-tube-cells-and-the-role-of-selective-estrogen-receptor-modulators
#3
Georgette Moyle-Heyrman, Matthew J Schipma, Matthew Dean, David A Davis, Joanna E Burdette
BACKGROUND: The fallopian tube epithelium is one of the potential sources of high-grade serous ovarian cancer (HGSC). The use of estrogen only hormone replacement therapy increases ovarian cancer (OVCA) risk. Despite estrogen's influence in OVCA, selective estrogen receptor modulators (SERMs) typically demonstrate only a 20 % response rate. This low response could be due to a variety of factors including the loss of estrogen receptor signaling or the role of estrogen in different potential cell types of origin...
2016: Journal of Ovarian Research
https://www.readbyqxmd.com/read/26648788/high-grade-serous-ovarian-cancer-cell-lines-exhibit-heterogeneous-responses-to-growth-factor-stimulation
#4
Danielle L Bourgeois, Karl A Kabarowski, Veronica L Porubsky, Pamela K Kreeger
BACKGROUND: The factors driving the onset and progression of ovarian cancer are not well understood. Recent reports have identified cell lines that are representative of the genomic pattern of high-grade serous ovarian cancer (HGSOC), in which greater than 90 % of tumors have a mutation in TP53. However, many of these representative cell lines have not been widely used so it is unclear if these cell lines capture the variability that is characteristic of the disease. METHODS: We investigated six TP53-mutant HGSOC cell lines (Caov3, Caov4, OV90, OVCA432, OVCAR3, and OVCAR4) for migration, MMP2 expression, proliferation, and VEGF secretion, behaviors that play critical roles in tumor progression...
2015: Cancer Cell International
https://www.readbyqxmd.com/read/26186970/transforming-growth-factor-%C3%AE-stimulates-human-ovarian-cancer-cell-migration-by-up-regulating-connexin43-expression-via-smad2-3-signaling
#5
Xin Qiu, Jung-Chien Cheng, Jianfang Zhao, Hsun-Ming Chang, Peter C K Leung
Reduced connexin43 (Cx43) expression is frequently detected in different types of human cancer. Cx43 has been shown to regulate cancer cell migration in a cell-type dependent manner. In both primary and recurrent human ovarian cancer, overexpression of TGF-β ligand and its receptors have been detected. TGF-β can regulate Cx43 expression in other cell types and stimulate human ovarian cancer cell migration. However, whether Cx43 can be regulated by TGF-β and is involved in TGF-β-stimulated cell migration in human ovarian cancer cells remain unknown...
October 2015: Cellular Signalling
https://www.readbyqxmd.com/read/26050922/in-vivo-tumor-growth-of-high-grade-serous-ovarian-cancer-cell-lines
#6
Anirban K Mitra, David A Davis, Sunil Tomar, Lynn Roy, Hilal Gurler, Jia Xie, Daniel D Lantvit, Horacio Cardenas, Fang Fang, Yueying Liu, Elizabeth Loughran, Jing Yang, M Sharon Stack, Robert E Emerson, Karen D Cowden Dahl, Maria V Barbolina, Kenneth P Nephew, Daniela Matei, Joanna E Burdette
OBJECTIVE: Genomic studies of ovarian cancer (OC) cell lines frequently used in research revealed that these cells do not fully represent high-grade serous ovarian cancer (HGSOC), the most common OC histologic type. However, OC lines that appear to genomically resemble HGSOC have not been extensively used and their growth characteristics in murine xenografts are essentially unknown. METHODS: To better understand growth patterns and characteristics of HGSOC cell lines in vivo, CAOV3, COV362, KURAMOCHI, NIH-OVCAR3, OVCAR4, OVCAR5, OVCAR8, OVSAHO, OVKATE, SNU119 and UWB1...
August 2015: Gynecologic Oncology
https://www.readbyqxmd.com/read/26031779/egf-induced-connexin43-negatively-regulates-cell-proliferation-in-human-ovarian-cancer
#7
Xin Qiu, Jung-Chien Cheng, Christian Klausen, Hsun-Ming Chang, Qianlan Fan, Peter C K Leung
Connexin43 (Cx43) has been shown to regulate cell proliferation and its downregulation is correlated with poor prognosis and survival in several types of human cancer. Cx43 expression levels are frequently downregulated in human ovarian cancer, suggesting a potential role for Cx43 in regulating the progression of this disease. Epidermal growth factor (EGF) is a well-characterized hormone that stimulates ovarian cancer cell proliferation. Although EGF is able to regulate Cx43 expression in other cell types, it is unclear whether EGF can regulate Cx43 expression in ovarian cancer cells...
January 2016: Journal of Cellular Physiology
https://www.readbyqxmd.com/read/25765713/sensitive-%C3%AE-galactosidase-targeting-fluorescence-probe-for-visualizing-small-peritoneal-metastatic-tumours-in-vivo
#8
Daisuke Asanuma, Masayo Sakabe, Mako Kamiya, Kyoko Yamamoto, Jun Hiratake, Mikako Ogawa, Nobuyuki Kosaka, Peter L Choyke, Tetsuo Nagano, Hisataka Kobayashi, Yasuteru Urano
Fluorescence-guided diagnostics is one of the most promising approaches for facile detection of cancer in situ. Here we focus on β-galactosidase, which is overexpressed in primary ovarian cancers, as a molecular target for visualizing peritoneal metastases from ovarian cancers. As existing fluorescence probes are unsuitable, we have designed membrane-permeable HMRef-βGal, in which the optimized intramolecular spirocyclic function affords >1,400-fold fluorescence enhancement on activation. We confirm that HMRef-βGal sensitively detects intracellular β-galactosidase activity in several ovarian cancer lines...
2015: Nature Communications
https://www.readbyqxmd.com/read/25624750/alisertib-an-aurora-kinase-a-inhibitor-induces-apoptosis-and-autophagy-but-inhibits-epithelial-to-mesenchymal-transition-in-human-epithelial-ovarian-cancer-cells
#9
Yong-Hui Ding, Zhi-Wei Zhou, Chun-Fang Ha, Xue-Yu Zhang, Shu-Ting Pan, Zhi-Xu He, Jeffrey L Edelman, Dong Wang, Yin-Xue Yang, Xueji Zhang, Wei Duan, Tianxin Yang, Jia-Xuan Qiu, Shu-Feng Zhou
Ovarian cancer is a leading killer of women, and no cure for advanced ovarian cancer is available. Alisertib (ALS), a selective Aurora kinase A (AURKA) inhibitor, has shown potent anticancer effects, and is under clinical investigation for the treatment of advanced solid tumor and hematologic malignancies. However, the role of ALS in the treatment of ovarian cancer remains unclear. This study investigated the effects of ALS on cell growth, apoptosis, autophagy, and epithelial to mesenchymal transition (EMT), and the underlying mechanisms in human epithelial ovarian cancer SKOV3 and OVCAR4 cells...
2015: Drug Design, Development and Therapy
https://www.readbyqxmd.com/read/25576358/epcam-is-up-regulated-by-egf-via-erk1-2-signaling-and-suppresses-human-epithelial-ovarian-cancer-cell-migration
#10
Qianlan Fan, Jung-Chien Cheng, Xin Qiu, Hsun-Ming Chang, Peter C K Leung
Although epithelial cell adhesion molecule (EpCAM) is overexpressed in human epithelial ovarian cancer (EOC), some contradictory results have been reported regarding the correlation between EpCAM overexpression and patient survival. In addition to this controversy, the function and regulation of EpCAM in EOC remain largely unknown. Here, we show that epidermal growth factor (EGF) up-regulates EpCAM expression by activating ERK1/2 signaling in a human EOC cell line, SKOV3. Additionally, EpCAM overexpression suppresses not only basal but also EGF-stimulated SKOV3 cell migration, whereas EpCAM knockdown increases both basal and EGF-stimulated cell migration in another human EOC cell line, OVCAR4...
February 13, 2015: Biochemical and Biophysical Research Communications
https://www.readbyqxmd.com/read/24999371/versican-regulates-metastasis-of-epithelial-ovarian-carcinoma-cells-and-spheroids
#11
Mark Desjardins, Jia Xie, Hilal Gurler, Goda G Muralidhar, Joelle D Sacks, Joanna E Burdette, Maria V Barbolina
BACKGROUND: Epithelial ovarian carcinoma is a deadly disease characterized by overt peritoneal metastasis. Individual cells and multicellular aggregates, or spheroids, seed these metastases, both commonly found in ascites. Mechanisms that foster spheroid attachment to the peritoneal tissues preceding formation of secondary lesions are largely unknown. METHODS: Cell culture models of SKOV-3, OVCAR3, OVCAR4, Caov-3, IGROV-1, and A2780 were used. In this report the role of versican was examined in adhesion of EOC spheroids and cells to peritoneal mesothelial cell monolayers in vitro as well as in formation of peritoneal tumors using an in vivo xenograft mouse model...
2014: Journal of Ovarian Research
https://www.readbyqxmd.com/read/24887420/preclinical-therapeutic-potential-of-a-nitrosylating-agent-in-the-treatment-of-ovarian-cancer
#12
Shailendra Giri, Ramandeep Rattan, Mandar Deshpande, Jacie L Maguire, Zachary Johnson, Rondell P Graham, Viji Shridhar
This study examines the role of s-nitrosylation in the growth of ovarian cancer using cell culture based and in vivo approaches. Using the nitrosylating agent, S-nitrosoglutathione (GSNO), a physiological nitric oxide molecule, we show that GSNO treatment inhibited proliferation of chemoresponsive and chemoresistant ovarian cancer cell lines (A2780, C200, SKVO3, ID8, OVCAR3, OVCAR4, OVCAR5, OVCAR7, OVCAR8, OVCAR10, PE01 and PE04) in a dose dependent manner. GSNO treatment abrogated growth factor (HB-EGF) induced signal transduction including phosphorylation of Akt, p42/44 and STAT3, which are known to play critical roles in ovarian cancer growth and progression...
2014: PloS One
https://www.readbyqxmd.com/read/24220856/human-cancer-cell-line-micrornas-associated-with-in-vitro-sensitivity-to-paclitaxel
#13
Ning Chen, Hye Sook Chon, Yin Xiong, Douglas C Marchion, Patricia L Judson, Ardeshir Hakam, Jesus Gonzalez-Bosquet, Jennifer Permuth-Wey, Robert M Wenham, Sachin M Apte, Jin Q Cheng, Thomas A Sellers, Johnathan M Lancaster
Paclitaxel is a mainstay of treatment for many solid tumors, and frequently, clinical outcome is influenced by paclitaxel sensitivity. Despite this, our understanding of the molecular basis of paclitaxel response is incomplete. Recently, it has been shown that microRNAs (miRNAs) influence messenger RNA (mRNA) transcriptional control and can contribute to human carcinogenesis. In the present study, our objective was to identify miRNAs associated with cancer cell line response to paclitaxel and to evaluate these miRNAs as therapeutic targets to increase paclitaxel sensitivity...
January 2014: Oncology Reports
https://www.readbyqxmd.com/read/20857490/transient-arrest-in-a-quiescent-state-allows-ovarian-cancer-cells-to-survive-suboptimal-growth-conditions-and-is-mediated-by-both-mirk-dyrk1b-and-p130-rb2
#14
Jing Hu, Hassan Nakhla, Eileen Friedman
Some ovarian cancer cells in vivo are in a reversible quiescent state where they can contribute to cancer spread under favorable growth conditions. The serine/threonine kinase Mirk/dyrk1B was expressed in each of seven ovarian cancer cell lines and in 21 of 28 resected human ovarian cancers, and upregulated in 60% of the cancers. Some ovarian cancer cells were found in a G0 quiescent state, with the highest fraction in a line with an amplified Mirk gene. Suboptimal culture conditions increased the G0 fraction in SKOV3 and TOV21G, but not OVCAR4 cultures...
July 15, 2011: International Journal of Cancer. Journal International du Cancer
https://www.readbyqxmd.com/read/19955938/gedunin-a-novel-natural-substance-inhibits-ovarian-cancer-cell-proliferation
#15
Siddharth G Kamath, Ning Chen, Yin Xiong, Robert Wenham, Sachin Apte, Marcia Humphrey, Janiel Cragun, Johnathan M Lancaster
The discovery of more active therapeutic compounds is essential if the outcome for patients with advanced-stage epithelial ovarian cancer is to be improved. Gedunin, an extract of the neem tree, has been used as a natural remedy for centuries in Asia. Recently, gedunin has been shown to have potential in vitro antineoplastic properties; however, its effect on ovarian cancer cells is unknown. We evaluated the in vitro effect of gedunin on SKOV3, OVCAR4, and OVCAR8 ovarian cancer cell lines proliferation, alone and in the presence of cisplatin...
December 2009: International Journal of Gynecological Cancer
https://www.readbyqxmd.com/read/17634556/rad001-inhibits-human-ovarian-cancer-cell-proliferation-enhances-cisplatin-induced-apoptosis-and-prolongs-survival-in-an-ovarian-cancer-model
#16
Seiji Mabuchi, Deborah A Altomare, Mitchell Cheung, Lili Zhang, Poulikos I Poulikakos, Harvey H Hensley, Russell J Schilder, Robert F Ozols, Joseph R Testa
PURPOSE: mTOR (mammalian target of rapamycin) plays a central role in regulating cell growth and cell cycle progression and is regarded as a promising therapeutic target. We examined whether mTOR inhibition by RAD001 (everolimus) is therapeutically efficacious in the treatment of ovarian cancer as a single agent and in combination with cisplatin. EXPERIMENTAL DESIGN: Using four human ovarian cancer cell lines, we determined the effect of RAD001 by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, Western blot, and apoptosis assays...
July 15, 2007: Clinical Cancer Research: An Official Journal of the American Association for Cancer Research
https://www.readbyqxmd.com/read/15208673/akt-and-mtor-phosphorylation-is-frequently-detected-in-ovarian-cancer-and-can-be-targeted-to-disrupt-ovarian-tumor-cell-growth
#17
Deborah A Altomare, Hui Qin Wang, Kristine L Skele, Assunta De Rienzo, Andres J Klein-Szanto, Andrew K Godwin, Joseph R Testa
Activation of the PI3K/AKT pathway may contribute to tumorigenesis. AKT mediates survival signals that protect cells from apoptosis and, thus, is a potentially important therapeutic target. To determine the frequency of AKT activation in human ovarian cancer, we screened a tumor tissue microarray with a phospho-specific pan-AKT (Ser473) antibody, which revealed elevated staining in 21 of 31 (68%) ovarian carcinomas. Phospho-AKT staining was associated with that of phospho (active)-mTOR in 27 of 31 (87%) ovarian tumors, with 17 (55%) tumors showing elevated phospho-mTOR positivity...
July 29, 2004: Oncogene
https://www.readbyqxmd.com/read/9178098/simultaneous-activity-of-two-different-mechanisms-of-folate-transport-in-ovarian-carcinoma-cell-lines
#18
S Miotti, M Bagnoli, F Ottone, A Tomassetti, M I Colnaghi, S Canevari
We investigated whether the folate receptor alpha-isoform (FR alpha), which is overexpressed on ovarian carcinoma cells, is functionally active in internalizing the physiological form et folate, 5-methyl tetrahydrofolate (THF). Six ovarian tumor cell lines, expressing different levels of FR alpha (COR > > OVCAR3 > IGROV1 > OVCAR4 > SKOV3 > OVCAR5), were maintained in folate-depleted medium and internalization of 10 nM evaluated as acid-resistant radioactivity at 0 degree and 37 degrees C. The amount of 5-methyl[1H]THF present in this fraction was not strictly related to the number of membrane receptors, since even cell lines with low FR alpha expression, e...
June 15, 1997: Journal of Cellular Biochemistry
https://www.readbyqxmd.com/read/8615620/growth-regulation-of-multidrug-resistant-ovarian-cancer-cells-by-1d7-monoclonal-antibody
#19
COMPARATIVE STUDY
X Yang, M Pagé
The small molecular weight protein (p7) was overexpressed in the human ovarian carcinoma cell lines, SKVLB600 (selected for vinblastine resistance from SKOV3 cells). OVCAR 4/ADR100 (selected for doxorubicin resistance from NIH:OVCAR4) and (OVCAR4/VBL200 (selected for vinblastine resistance from NIH:OVCAR4). Trace amounts of the protein were also found in the parent cell lines, SKOV3 and NIH: OVCAR4. An anti-p7 monoclonal antibody (1D7) specifically inhibited the proliferation of the drug resistant cancer cells...
January 1996: Anticancer Research
https://www.readbyqxmd.com/read/7874690/an-m-r-7-kda-membrane-protein-overexpressed-in-human-multidrug-resistant-ovarian-cancer-cells
#20
X Yang, M Pagé
We have developed a monoclonal antibody (designated 1D7) which recognizes an M(r) 7-kDa plasma membrane protein overexpressed in ovarian MDR cancer cells. The expression of the M(r) 7-kDa protein in various human multidrug-resistant and drug-sensitive cell lines was analysed by Western blot and flow cytometry methods. The small molecular weight protein was overexpressed in the human ovarian carcinoma cell line, SKVLB which was selected for vinblastine resistance from SKOV3 cells and in OVCAR 4/ADR100 and OVCAR 4/VBL200 which were generated from NIH:OVCAR4 by stepwise selection against adriamycin and vinblastine, respectively...
January 27, 1995: Cancer Letters
keyword
keyword
102229
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"